Version 2.77

Term Description

Sex chromosome (X & Y) analysis to determine gender (XY or XX) or presence of aneuploidy can be determined based on dosage of chromosome specific ccf DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age. The submitter's lab reports results as male fetus, female fetus, or aneuploidy. For aneuploidy cases, the results of the specific findings (e.g. YY, XYY, XXX, etc.) are reported as well.
Source: Regenstrief LOINC

Fully-Specified Name

Component
Fetal chromosome X & Y aneuploidy
Property
Find
Time
Pt
System
Plas.cfDNA
Scale
Nom
Method
Dosage of chromosome specific cf DNA

Additional Names

Short Name
Chr X + Y aneup Plas.cfDNA
Display Name
Chr X and Y aneuploidy Dosage of chromosome-specific cfDNA Nom (cfDNA)
Consumer Name Alpha Get Info
Fetal Chromosome X and Y Aneuploidy

Example Answer List: LL2479-5

Source: Laboratory Corporation of America
Answer Code Score Answer ID
Male fetus (XY) LA19938-2
Female fetus (XX) LA19939-0
Aneuploidy LA19940-8

Basic Attributes

Class
MOLPATH
Type
Laboratory
First Released
Version 2.44
Last Updated
Version 2.73
Change Reason
The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured. Changed Component from 'X & Y chromosome analysis' to clarify that the purpose of the measurement is to look for aneuploidy.; Added "Fetal" to Component to clarify that the result is about the fetus.
Order vs. Observation
Both
Common Test Rank Get Info
7043

Member of these Panels

LOINC Long Common Name
73967-2 Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Aneuploidía de los cromosmas fetales X e Y:Hallazgo:Punto temporal:ADN en plasma libre de células:Nom:Dosificación de ADN ccf de cromosoma específico
es-MX Spanish (Mexico) Aneuploidía fetal de los cromosomas X e Y:Hallazgo:Punto temporal:ADN libre de células plasmáticas:Nominal:Dosis de cfDNA cromosómico específico
fr-FR French (France) Chromosomes X et Y aneuploïdie foetale:Recherche:Ponctuel:Plasma avec ADN libre circulant:Résultat nominal:Dosage d'ADN libre circulant spécifiques aux chromosomes
it-IT Italian (Italy) Cromosomi X & Y, aneuploidia:Osservazione:Pt:Plasma.DNA libero circolante:Nom:Dosaggio di DNA libero fetale circolante cromosoma specifico
Synonyms: Aneuploidia dei cromosomi X e Y DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Osservazione Patologia molecolare Plasma Punto nel tempo (episodio)
pl-PL Polish (Poland) Aneuploidia chromosomów X & Y u płodu:wynik:punkt w czasie:pozakomórkowy DNA w osoczu:cecha:dawkowanie swoistego dla chromosomu pozakomórkowego DNA
Synonyms: Aneuploidia chromosomów X i Y Aneuploidia chromosomów X i Y płodu
pt-BR Portuguese (Brazil) Cromossomos X& Y análise:Achado:Pt:Soro/Plas maternal^feto:Nom:Dosagem de cromossomo específico ccf DNA
zh-CN Chinese (China) 胎儿染色体 X & Y 非整倍体性:发现:时间点:血浆.cfDNA:名义型:染色体特异性 cfDNA 剂量测定
Synonyms: 分子病理学;分子病理学试验 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 发现是一个原子型临床观察指标,并不是作为印象的概括陈述。体格检查、病史、系统检查及其他此类观察指标的属性均为发现。它们的标尺对于编码型发现可能是名义型,而对于叙述型文本之中所报告的发现,则可能是叙述型。;发现物;所见;结果;结论 时刻;随机;随意;瞬间 染色体 X 与 Y 非整倍体性(非整倍体型、非整倍体、异倍体、非整倍性、异倍性、非整倍态、异倍体性);X 与 Y 染色体非整倍体性 染色体二体型+染色体三体型 染色体特异性 cf DNA 剂量测定;染色体特异性游离循环 DNA 剂量测定;染色体特异性循环游离 DNA 剂量测定;Cell Free DNA 特异 特异性的 特异的 胎儿染色体 X & Y 非整倍体性(非整倍体型、非整倍体、异倍体、非整倍性、异倍性、非整倍态、异倍体性) 血浆循环 cfDNA;血浆循环 DNA;循环游离核酸;血浆游离 DNA;血浆无细胞 DNA;Free circulating/Cell-free DNA;Free circulating DNA

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=73822-9